Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × Citalopram × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Depression 1 Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 2 Ketamine 2 Cognitive Behavioral Therapy 2 Waiting Lists 1 Uncertainty 1 Therapeutics 1 Single Person 1 Psychosocial Intervention 1 Pharmacogenomic Testing 1 Mindfulness-Based Stress Reduction 1 Midazolam 1 Interviews as Topic 1 Drug Therapy 1 Control Groups 1 Citalopram 1 Behavior Therapy 1 Analgesia 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Kalaco Scientific, Inc.

Phase 2 Completed

Anxiety Disorders, Depression, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡